Relationship between Protein and Metabolite in Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 25 October 2024 | Viewed by 54
Special Issue Editor
Special Issue Information
Dear Colleagues,
The intricate interplay between proteins and metabolites in the realm of cancer represents a captivating frontier in scientific exploration. This dynamic relationship, explored in the upcoming Special Issue titled "Relationship between Protein and Metabolite in Cancers" promises to unveil novel insights into the molecular intricacies that underlie cancer progression. From deciphering signaling pathways to understanding metabolic dysregulations, this collection of research articles aims to shed light on the pivotal role played by proteins and metabolites in orchestrating the complex cellular processes within cancer cells. As we delve into this multifaceted connection, we anticipate that the revelations within this Special Issue will deepen our comprehension of cancer biology and pave the way for innovative therapeutic strategies and interventions. It is an exciting journey into the heart of molecular intricacies, poised to redefine our understanding of cancer at its core.
Dr. Md. Wasim Khan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer progression
- cancer cells
- proteins
- metabolites
- signaling pathway
- metabolic dysregulations
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Unveiling the Maze: Branched-Chain Amino Acids Fueling the Dynamics of Cancer Metabolism and Progression
Authors: Md. Wasim Khan
Affiliation: Endocrinology/Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, USA
Abstract: This review delves into the intricate landscape of cancer metabolism, focusing on the pivotal role played by branched-chain amino acids (BCAAs). As essential contributors to protein synthesis and signaling pathways regulating cell growth, BCAAs have emerged as key players in the progression of cancer. The exploration of their nuanced impact on cellular processes unveils a complex interplay, influencing not only energy dynamics but also intricate signaling networks. The review navigates through recent insights, shedding light on the unexplored territories where BCAAs act as fuel, propelling the dynamics of cancer metabolism and contributing to the progression of malignancies. Understanding these branched mysteries opens new avenues for therapeutic interventions and unveils potential targets for disrupting the metabolic underpinnings of cancer.
